Psychiatry · Dearborn, MI
NPI
1821057159
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
2314 Monroe St
Dearborn, MI, 48124
Phone (313) 562-6633
Groups this clinician bills Medicare through
Medicare paid, 2023
$7,346
95 services
Medicare patients, 2023
17
Average age 61
Drug cost, 2024
$9,022
601 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alicja D Wasilewski prescribed most often to Medicare patients was Lamotrigine, with 169 prescriptions and refills. In total Alicja D Wasilewski wrote 601 Medicare prescriptions that cost $9,022.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lamotrigine Generic | 169 | 173 | 16 | $1,032 |
| Quetiapine Fumarate Generic | 41 | 41 | Under 11 | $459 |
| Citalopram Hbr Citalopram Hydrobromide | 40 | 40 | Under 11 | $140 |
| Clonazepam Generic | 39 | 39 | Under 11 | $61.48 |
| Lurasidone Hcl Generic | 37 | 37 | Under 11 | $403 |
| Alprazolam Generic | 28 | 28 | Under 11 | $84.36 |
| Escitalopram Oxalate Generic | 26 | 26 | Under 11 | $176 |
| Prazosin Hcl Generic | 20 | 20 | Under 11 | $257 |
| Aripiprazole Generic | 18 | 18 | Under 11 | $176 |
| Subvenite Lamotrigine | 16 | 16 | Under 11 | $176 |
| Bupropion Xl Bupropion Hcl | 16 | 16 | Under 11 | $54.23 |
| Risperidone Generic | 15 | 15 | Under 11 | $40.26 |
| Doxepin Hcl Generic | 13 | 13 | Under 11 | $111 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 13 | 15 | Under 11 | $267 |
| Diazepam Generic | 12 | 12 | Under 11 | $42.15 |
Brand drugs: - claims; generic drugs: 599 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alicja D Wasilewski were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.